Ferring courts sporting seniors for Euflexxa

Share this article:
Sports sponsorships and awareness campaigns aimed at seniors are staples of pharmaceutical communications. Ferring Pharmaceuticals has found a way to combine them with a multi-year sponsorship of the National Senior Games Association on behalf of its osteoarthritis treatment Euflexxa.

The Suffern, NY-based company will serve as an exclusive sponsor of the Summer National Senior Games—The Senior Olympics Presented by Humana, to be held from June 22-July 7 in Louisville, KY. Representing the brand at the games will be 1976 Olympic gold medalist and OA sufferer Bruce Jenner.

Ferring's William Garbarini, executive director for sales and marketing, said in a statement: “Our goal is to educate people about knee osteoarthritis and the available treatment options while supporting those who live with it every day. What better way to promote active aging than to be a part of an event as important as the Senior Games?”

The Games are billed as “the largest multi-sport event in the world for seniors 50 and over.” This year's event is expected to draw more than 12,000 athletes and 45,000 attendees over its 16 days.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...